STERIS (STE)
(Delayed Data from NYSE)
$203.90 USD
+2.36 (1.17%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $203.96 +0.06 (0.03%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth C Momentum C VGM
Price, Consensus and EPS Surprise
STE 203.90 +2.36(1.17%)
Will STE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for STE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STE
Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?
Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
STE: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks
Here's Why Investors Should Retain STERIS (STE) Stock for Now
Other News for STE
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
Top 10 most oversold S&P 500 stocks
Interesting STE Put And Call Options For December 20th
Steris PLC stock underperforms Tuesday when compared to competitors
Steris: Moving On, Losing Its Teeth